Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine vs Megestrol for Cancer Anorexia-Cachexia
NCT03283488Phase 2Completed
- Sponsor
- Universidade de São Paulo
- Start
- Mar 2019
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mirtazapine in cancer anorexia-cachexia syndrome (CACS), sponsored by Universidade de São Paulo. Started Mar 2019; status: completed.
02
Drugs
mirtazapine
03
Conditions
cancer anorexia-cachexia syndrome (CACS)
Beyond the preview
Go deeper on NCT03283488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03283488.